All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-36992510

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	36992510	A1020T	S	S	COVID-19	G R S C L	View
2	36992510	A372S	S	S	COVID-19	G R S C L	View
3	36992510	A67T	S	S	COVID-19	G R S C L	View
4	36992510	D1163Y	S	S	COVID-19	G R S C L	View
5	36992510	D614G	S	S	COVID-19	G R S C L	View
6	36992510	D950N	S	S	COVID-19	G R S C L	View
7	36992510	E1202Q	S	S	COVID-19	G R S C L	View
8	36992510	E156G	S	S	COVID-19	G R S C L	View
9	36992510	E281Q	S	S	COVID-19	G R S C L	View
10	36992510	G1124C	S	S	COVID-19	G R S C L	View
11	36992510	G1219C	S	S	COVID-19	G R S C L	View
12	36992510	G1267R	S	S	COVID-19	G R S C L	View
13	36992510	G142D	S	S	COVID-19	G R S C L	View
14	36992510	I742N	S	S	COVID-19	G R S C L	View
15	36992510	I850L	S	S	COVID-19	G R S C L	View
16	36992510	L452R	S	S	COVID-19	G R S C L	View
17	36992510	M153I	S	S	COVID-19	G R S C L	View
18	36992510	N185D	S	S	COVID-19	G R S C L	View
19	36992510	P174S	S	S	COVID-19	G R S C L	View
20	36992510	P330L	S	S	COVID-19	G R S C L	View
21	36992510	P681R	S	S	COVID-19	G R S C L	View
22	36992510	T19R	S	S	COVID-19	G R S C L	View
23	36992510	T250I	S	S	COVID-19	G R S C L	View
24	36992510	T29A	S	S	COVID-19	G R S C L	View
25	36992510	T478K	S	S	COVID-19	G R S C L	View
26	36992510	T696S	S	S	COVID-19	G R S C L	View
27	36992510	T95I	S	S	COVID-19	G R S C L	View
28	36992510	V1228L	S	S	COVID-19	G R S C L	View
29	36992510	V382L	S	S	COVID-19	G R S C L	View
30	36992510	V915I	S	S	COVID-19	G R S C L	View
31	36992510	A119S	N	N	COVID-19	G R S C L	View
32	36992510	A359S	N	N	COVID-19	G R S C L	View
33	36992510	D377Y	N	N	COVID-19	G R S C L	View
34	36992510	D63G	N	N	COVID-19	G R S C L	View
35	36992510	E253D	N	N	COVID-19	G R S C L	View
36	36992510	G215C	N	N	COVID-19	G R S C L	View
37	36992510	L139S	N	N	COVID-19	G R S C L	View
38	36992510	P364L	N	N	COVID-19	G R S C L	View
39	36992510	R203M	N	N	COVID-19	G R S C L	View
40	36992510	R319H	N	N	COVID-19	G R S C L	View
41	36992510	R41Q	N	N	COVID-19	G R S C L	View
42	36992510	S232G	N	N	COVID-19	G R S C L	View
43	36992510	T24I	N	N	COVID-19	G R S C L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.